Entry into a Material Definitive Agreement

Business Context and Reporting Period

This Form 8-K filing by National Healthcare Properties, Inc. (NHP) reports on events occurring between April 21, 2026, and April 27, 2026. The filing details the execution of a material definitive agreement regarding a registered underwritten public offering of Class A common stock.

Key Financial Metrics and Transaction Details

  • Primary Offering: 38,500,000 shares of Class A common stock closed on April 23, 2026.
  • Overallotment Option: Underwriters exercised an option to purchase an additional 5,775,000 shares (Option Shares).
  • Total Shares Issued: 44,275,000 shares (38,500,000 primary + 5,775,000 option).
  • Closing Dates: Primary offering closed April 23, 2026; Option Shares expected to close April 28, 2026.
  • Underwriters: Wells Fargo Securities, LLC; Morgan Stanley & Co. LLC; BMO Capital Markets Corp.
  • Financial Metrics: The filing text does not provide a clear value for the offering price per share, total gross proceeds, net proceeds, or specific impacts on revenue, profit, cash flow, margins, debt, or liquidity.

Material Changes Versus Prior Period

The filing does not provide comparative financial data or a discussion of material changes in operating results versus prior periods. The primary material change is the increase in outstanding Class A common stock resulting from the equity offering.

Guidance, Outlook, and Risks

Management Commentary: The filing confirms the successful closing of the offering and the exercise of the overallotment option. It references the Underwriting Agreement for customary representations, warranties, and indemnification obligations.

Risks and Contingencies: The filing notes that the Underwriting Agreement contains termination provisions and indemnification obligations for liabilities under the Securities Act. No specific forward-looking guidance or risk factors are detailed in this excerpt.

Investor Verification Checklist

  • Verify the public offering price per share and total gross proceeds in the related Form S-11 (File No. 333-294895) or press releases, as these figures are absent from this 8-K text.
  • Confirm the final closing date and settlement of the 5,775,000 Option Shares on or around April 28, 2026.
  • Review the full Underwriting Agreement (Exhibit 1.1) for specific lock-up periods, underwriting discounts, and indemnification terms.
  • Assess the dilution impact of the 44,275,000 new shares on existing shareholders.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.